Cancer

Cancer

Cancer research

Clinical Trials

Performance of clinical trials is a departmental priority. The department and affiliated programs are conducting investigational studies of treatments for genitourinary cancer and other conditions with the goal of improving diagnosis, treatment, and follow-up of urologic disease. Learn more at the Helen Diller Family Comprehensive Cancer Center.

Learn More

UCSF is internationally known for its research in prostate and other urological cancers. Our department conducts basic scientific work to analyze and categorize different types of prostate cancer and the health risks they pose. Our faculty lead large epidemiological studies on dietary and other lifestyle interventions that may help reduce the risk of the disease. UCSF Urology also heads CaPSURE™, a multicenter longitudinal study of men with prostate cancer.

In addition to our work in prostate cancer, we have important research programs in bladder, renal and other urological cancers. The department conducts clinical trials of new treatments for genitourinary cancers, coordinated through the urologic clinical and translational science program. We also maintain a urologic oncology database, which provides a valuable repository of information to guide future investigations. Many of our faculty maintain research laboratories at UCSF, where they conduct basic science investigations in their areas of expertise.

Cancer News & Highlights

The month of April is dedicated to raising awareness about this highly treatable and usually curable disease. The testicles are two egg-shaped structures with a firm, slightly spongy feel located...
The California Prostate Cancer Coalition (CPCC) and the Helen Diller Family Comprehensive Cancer Center of UCSF will host a national conference on prostate cancer for patient, families, caregivers,...
The New York Times published new research by Professor of Urology, Robert Blelloch, MD, PhD titled, Cancer’s Trick for Dodging the Immune System.  The original research, published in the journal Cell...
Physician scientist Hao G. Nguyen, MD, PhD, has been appointed to the newly established Goldberg-Benioff Endowed Professorship in Cancer Biology. This professorship will help support Nguyen’s basic...
Davide Ruggero, PhD et al published "Translation control of the immune checkpoint in cancer and its therapeutic targeting" in Nature Medicine.  Explains UCSF.edu's Nicoletta Lanesse, their "...
UCSF featured Urology researcher, Luke Gilbert, PhD highlighting NIH grant award for, "High-Risk, High Reward" research. Click here for full story. 
The presentation, “Genomic screening should be done,” presented by Matt Cooperberg, MD, MPH at the European Association of Urology 2018 conference held in March 2018 has been chosen as a Selected...